4.3 Managing Conflicts of Interest & Maintaining Confidentiality

4.3 Managing Conflicts of Interest & Maintaining Confidentiality

Quick Summary: Conflicts of interest arise whenever a research firm or its analysts face competing institutional incentives—such as lucrative investment banking underwriting fees or proprietary trading gains—that could compromise research objectivity. SEBI regulations strictly prohibit tying analyst compensation to corporate finance transactions and require segregated reporting lines. Concurrently, draft research reports must be treated with absolute confidentiality to eliminate front-running and selective tipping, ensuring fair and simultaneous dissemination to all eligible investors.

The Anatomy of Conflicts of Interest in Financial Institutions

In modern capital markets, equity research rarely operates as an isolated boutique. Most research departments are embedded within diversified financial conglomerates that simultaneously provide investment banking, merchant banking, institutional stockbroking, margin lending, wealth management, and proprietary trading services.

This multi-service structure generates inherent commercial tensions. A Conflict of Interest arises whenever the commercial interests of the financial intermediary, its corporate clients, or its employees compete with the professional duty owed to public investors and research subscribers. When conflicts are left unmanaged, research integrity collapses: analysts face intense internal pressure to issue glowing "Buy" ratings on weak companies to win multimillion-rupee underwriting mandates, or research releases are strategically timed to facilitate proprietary trading profits.

Under Regulation 15 of the SEBI (Research Analysts) Regulations, 2014, research analysts and research entities must have written internal policies and control procedures governing dealing and trading by research analysts, to address conflicts of interest, promote objective and reliable research, and prevent research from being used to manipulate the market. Regulation 15(2) also requires mechanisms that keep research independent of other business activities, and Regulation 16 limits personal trading.

Primary Sources of Conflict in Research Operations

Understanding the primary vectors of conflict is essential for both core analysts and Persons Associated with Research Services (PARS):

1. Proprietary Trading Desks vs. Client Research

• Front-Running (Trading Ahead of Research): If a research firm's proprietary trading desk learns that an analyst is about to issue a massive upgrade with an aggressive target price on a mid-cap stock, the trading desk has an incentive to purchase large blocks of shares before the report is published. Once the public report triggers client buying volume, the desk sells out at inflated prices. This constitutes illegal front-running and fraudulent market manipulation under SEBI PFUTP Regulations.
• Inventory Dumping: A firm holding a distressed, illiquid proprietary block of equity may pressure its research department to issue an optimistic recommendation, creating sufficient market liquidity for the firm to dump its holding onto unsuspecting retail subscribers.

2. Investment Banking Relationships vs. Objective Research

• Mandate Chasing: Investment banking divisions generate substantial fee income by underwriting Initial Public Offerings (IPOs), Follow-on Public Offers (FPOs), qualified institutional placements (QIPs), and M&A advisory deals. Corporate issuers frequently demand favorable equity research coverage as an unspoken precondition for awarding these lucrative mandates.
• Silencing Downgrades: If a covered company is a long-standing corporate finance client of the firm, investment bankers may pressure research analysts to conceal operational deterioration or withhold a "Sell" downgrade to avoid offending corporate management.

3. Corporate Access Intimidation

Listed corporate managements often attempt to discipline independent analysts. An issuer unhappy with a critical research note may threaten to revoke "corporate access"—refusing to permit the analyst onto post-earnings conference call question queues, barring them from plant visits, or denying them one-on-one meetings. Weak research departments capitulate to this intimidation by toning down legitimate criticisms.

4. Personal Financial Interests of Analysts

An analyst who owns shares, stock options, or convertible debentures in a covered company has an obvious personal incentive to issue promotional research to drive up the share price before liquidating their holdings.

Statutory Safeguards & Remuneration Governance

To dismantle these institutional conflicts, the SEBI RA Regulations enforce structural organizational firewalls and remuneration controls:

1. Prohibition on Transaction-Linked Remuneration (Regulation 17)

Under Regulation 17(1), a research entity must not pay a research analyst any bonus, salary or other compensation that is determined by or based on a specific merchant banking, investment banking or brokerage services transaction.

• Banned Practices: An analyst cannot receive a "deal bonus," "origination fee percentage," or incentive pool allocation tied to an IPO or QIP transaction completed by the firm's investment banking department.
• Board-Level Review: Under Regulation 17(2), the compensation of all research analysts must be reviewed, documented and approved annually by the board of directors or a board committee with no representation from the merchant banking, investment banking or brokerage divisions. Under Regulation 17(3), the reviewers must not take into account the analyst's contribution to those businesses. Firms typically assess analysts on:
  1. The analytical quality, rigor, and depth of the published research;
  2. The long-term accuracy of earnings models and investment ratings;
  3. Client satisfaction ratings regarding research responsiveness and insight;
  4. Strict adherence to compliance policies and professional ethics.

2. Independence from Banking and Sales (Regulations 17(4) and 18)

To ensure operational independence, research analysts must work within a protected reporting structure:

• No Supervision by Banking or Brokerage: Under Regulation 17(4), an employed research analyst must not be subject to the supervision or control of any employee of the merchant banking, investment banking or brokerage divisions. Regulation 18(10) requires analysts to be kept separate from staff doing sales trading, dealing, corporate finance advisory or other activities that may affect independence, although analysts may receive feedback from sales or trading staff to gauge a report's impact.
• Dedicated Research Leadership: Research analysts report exclusively to an independent Head of Research or directly to the firm's Board of Directors / Chief Executive Officer.
• No Banking Influence over Content: Regulation 18(4) bars research analysts from sales pitches and deal roadshows for investment banking business, Regulation 18(6) bars banking or brokerage staff from directing analysts to market their transactions, and Regulation 18(8) bars any promise of a favourable review to win business. Firms therefore limit pre-publication review to compliance or legal staff checking facts and disclosures.

Confidentiality Obligations, Draft Protocols & Fair Dissemination

Maintaining the absolute confidentiality of unpublished research reports is both a legal duty and an ethical necessity under SEBI regulations.

Legal Status of Pre-Publication Draft Research

A draft research report containing an upcoming rating revision (e.g., an unexpected upgrade to 'Strong Buy' or a severe downgrade to 'Sell') or a substantial target price change is confidential, non-public information. The Code of Conduct in the Third Schedule requires a report to be kept confidential until it is made public and prohibits front running of the firm's own research report, and Regulation 22(1) forbids making a report available selectively to internal trading staff or particular clients ahead of other entitled clients.

Prohibition on Selective Disclosure and Advance Tipping

• No Sneak Peeks to Favored Clients: Research personnel and PARS are strictly prohibited from providing advance copies, verbal previews, or "whisper numbers" to favored institutional clients, large high-net-worth investors, or hedge funds before official publication.
• No Internal Tipping to Trading Desks: Research staff cannot inform the firm's proprietary trading desks or institutional sales traders of upcoming rating changes.

Secure Handling of Draft Research Materials

Firms must implement rigorous digital security protocols to prevent data leakage during report preparation:

• Draft reports must be stored on encrypted, access-restricted network drives accessible only to the authoring analyst team and the compliance officer.
• Drafts must never be sent via personal webmail accounts, shared over external cloud drives, or discussed on unmonitored instant messaging apps (e.g., WhatsApp, Telegram).

The Mandate of Fair and Simultaneous Dissemination

When a research report is finalized and approved by compliance, it must reach all eligible subscribers at the same time, because Regulation 22(1) bars selective advance release:

• A firm cannot create "tiered release schedules" where top-paying hedge funds receive a report at 8:00 AM, standard institutional clients receive it at 9:00 AM, and retail subscribers receive it at market close.
• Every client entitled to receive the research must be granted access at the exact same instant via official portal alerts or automated email broadcast systems.

Frontline Obligations of PARS in Conflict Mitigation

Persons Associated with Research Services (PARS) serve as the vital link between research analysts and external clients. Consequently, they are frequently exposed to commercial pressures and ethical dilemmas:

Resisting Client Demands for Advance Information

Institutional clients and active traders frequently probe PARS representatives for early insights, asking questions such as: "Is your auto analyst going to downgrade Company X after today's poor sales numbers?" or "Can you send me a sneak peek of tomorrow morning's sector review?"

• Mandatory Response: The PARS must firmly state that research publication schedules and draft notes are strictly confidential under SEBI regulations. They must decline to speculate or disclose upcoming calls.
• Escalation Protocol: Any aggressive or persistent attempt by an external client or internal trader to solicit advance research information must be formally documented and escalated to the Compliance Officer.

Maintaining Marketing Objectivity

When presenting published research notes to prospective subscribers, PARS must never exaggerate target returns, make misleading promises of risk-free gains, or distribute unauthorized summaries that obscure analyst risk factors.

The Whistleblower Duty

If a PARS discovers that an internal sales desk is trading ahead of research releases, or that an investment banker is attempting to alter an analyst's earnings model, the PARS has an affirmative professional duty to report the breach immediately through the firm's internal vigil mechanism or compliance escalation channel.